Clinical Trials on Inherited Metabolic Storage Diseases in New Zealand
Total 6788 results
-
BioMarin PharmaceuticalTerminatedPompe DiseaseUnited States, United Kingdom, Australia, France, Germany, New Zealand
-
AldagenTerminatedMucopolysaccharidosis | Inborn Errors of Metabolism | Lysosomal Storage Disorders | Inherited Metabolic Diseases | Peroxisomal Storage DiseasesUnited States
-
Arcturus Therapeutics, Inc.CompletedOrnithine Transcarbamylase DeficiencyNew Zealand
-
OrsoBio, IncRecruitingInsulin ResistanceNew Zealand
-
Christchurch Women's HospitalCompletedHyperglycaemiaNew Zealand
-
Amicus TherapeuticsActive, not recruitingPompe DiseaseUnited States, Netherlands, United Kingdom, Australia, Germany, New Zealand
-
University of Auckland, New ZealandCompleted
-
Arthrosi TherapeuticsCompletedGout PatientsNew Zealand
-
Edgar National Centre for Diabetes ResearchCompletedInsulin ResistanceNew Zealand
-
Insulet CorporationCompleted
-
North Shore Hospital, New ZealandCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Zhejiang Doer Biologics Co., Ltd.RecruitingHealthy, Obesity, MetabolicallyNew Zealand
-
Diatranz Otsuka LimitedCompleted
-
University of OtagoEdgar National Centre for Diabetes ResearchCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Edgar National Centre for Diabetes ResearchUniversity of OtagoUnknown
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Columbia UniversityWithdrawnGlycogen Storage Disease Type IIUnited States
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsCompletedHyperglycemiaSingapore, United Kingdom, New Zealand
-
Christchurch HospitalUnknownDiabetes Mellitus, Type 2New Zealand
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe Disease Infantile-OnsetUnited States, France, South Africa
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Glycogenosis 2United States
-
Academy of Nutrition and DieteticsCompletedEnd Stage Renal Disease Requiring HemodialysisNew Zealand
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II)United States, Russian Federation, United Kingdom, Bulgaria, India, Ukraine
-
Amicus TherapeuticsCompletedPompe Disease (Late-onset)United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
-
Amicus TherapeuticsCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
Liggins InstituteNovo Nordisk A/SCompleted
-
Eisai Co., Ltd.Completed
-
Hoffmann-La RocheCompletedEnd Stage Renal DiseaseNew Zealand
-
Suzhou Alphamab Co., Ltd.Novotech (Australia) Pty LimitedRecruiting
-
Amicus TherapeuticsRecruitingPompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyTerminatedGlycogenosis 2 | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency | Pompe Disease (Infantile-Onset)United States, Taiwan, Germany
-
University of Auckland, New ZealandHealth Research Council, New ZealandCompletedObesity | Bariatric Surgery CandidateNew Zealand
-
ShireCompletedGaucher DiseaseIndia
-
ISU Abxis Co., Ltd.CompletedGaucher DiseaseAustralia
-
Alvotech Swiss AGCompleted
-
MetaventionCompletedDiabetes | Endocrine, Nutritional and Metabolic Diseases (E00-E89)New Zealand
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type II-Pompe's DiseaseUnited States, France, Japan, Taiwan, United Kingdom
-
NYU Langone HealthGenzyme, a Sanofi CompanyCompleted
-
Living Cell TechnologiesCompletedParkinson's DiseaseNew Zealand
-
Living Cell TechnologiesStatistecol Consultants LimitedCompleted
-
Amicus TherapeuticsTerminatedLate-onset Pompe DiseaseUnited States, Canada, Australia, Belgium
-
University of Auckland, New ZealandAuckland Medical Research FoundationCompletedMorbid ObesityNew Zealand
-
Exsar CorporationSuspendedType I Gaucher DiseaseUnited States
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand